No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
266 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Who this trial is looking for
This trial is looking for adults with lung cancer who are having surgery. Participants will receive an inhaled medication to see if it helps prevent problems with their lungs after surgery.
Are You a Good Fit for This Trial?
Must not be takingLong-acting bronchodilators
Rules you outSevere heart failureUncontrolled diabetesThyrotoxicosisPheochromocytoma
You may be able to join if
I am over 18 years old
I have lung cancer that can be treated with surgery
I have not used long-term inhaled medications before
I am at high risk for lung complications after surgery
You may not be able to join if
I do not want to participate
I am pregnant
I require emergency surgery
I have a serious illness (WHO IV or ASA ≥ IV)
I have asthma
I have severe heart failure or unstable heart disease
I have had a stroke in the past 3 months
I am currently in another trial for a different medication
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The objective of the study is to evaluate, in a clinical trial, the efficacy of peri operative administration of long-acting inhaled ß-2 mimetics on the occurrence of postoperative pulmonary complications
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Adult (\>18 years)
* Lung cancer eligible for surgical management by lung resection (non-small cell lung carcinoma = NSCLC) by any route
* Naïve to long-term inhaled bronchodilator therapy
* High risk of post-operative pulmonary complications (Pre-operative FEV1 \< 80%)
Exclu…
Inclusion Criteria:
* Adult (\>18 years)
* Lung cancer eligible for surgical management by lung resection (non-small cell lung carcinoma = NSCLC) by any route
* Naïve to long-term inhaled bronchodilator therapy
* High risk of post-operative pulmonary complications (Pre-operative FEV1 \< 80%)
Exclusion Criteria:
* Patient refusal
* Pregnancy
* Emergency surgery
* Patient with a physiological status of WHO IV or ASA ≥ IV
* Asthma
* Patients treated with long-acting bronchodilators
* Severe heart failure (NYHA IV), unstable ischaemic heart disease (angina or recent infarction \< 3 months), obstructive hypertrophic cardiomyopathy, subvalvular aortic stenosis, severe uncontrolled hypertension Recent stroke \< 3 months
* High-grade unresponsive conductive disorders or unstable arrhythmia
* Thyrotoxicosis, pheochromocytoma
* Unbalanced diabetes
* Hypersensitivity to ß-2 mimetics or lactose
* Current participation in a trial of another drug therapy
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
